These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30208223)

  • 21. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
    Yang Y; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
    Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac axis shift within the cardiac cycle of normal fetuses and fetuses with congenital heart defect.
    Zhao Y; Abuhamad S; Sinkovskaya E; Mlynarczyk M; Romary L; Abuhamad A
    Ultrasound Obstet Gynecol; 2015 Nov; 46(5):558-63. PubMed ID: 25511021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the fetal heart at 14 to 18 weeks' gestation in fetuses with a screening nuchal translucency greater than or equal to the 95th percentile.
    Foy PM; Wheller JJ; Samuels P; Evans KD
    J Ultrasound Med; 2013 Oct; 32(10):1713-9. PubMed ID: 24065251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal values of cardiac axis (CA) measurements in healthy fetuses during the first trimester screening ultrasound.
    Kesrouani A; Abdallah W; Kharrat R; Choueiry E; Daou L; Nasr B
    J Perinat Med; 2021 May; 49(4):496-499. PubMed ID: 33470962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of congenital heart defects throughout pregnancy; impact of first trimester ultrasound screening for cardiac abnormalities.
    Eleftheriades M; Tsapakis E; Sotiriadis A; Manolakos E; Hassiakos D; Botsis D
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2546-50. PubMed ID: 22712625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuchal translucency and cystic hygroma colli in screening for fetal major congenital heart defects in a series of 12,910 euploid pregnancies.
    Sananes N; Guigue V; Kohler M; Bouffet N; Cancellier M; Hornecker F; Hunsinger MC; Kohler A; Mager C; Neumann M; Schmerber E; Tanghe M; Nisand I; Favre R
    Ultrasound Obstet Gynecol; 2010 Mar; 35(3):273-9. PubMed ID: 20069678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between increased nuchal translucency and second trimester cardiac echogenic foci.
    Prefumo F; Presti F; Thilaganathan B; Carvalho JS
    Obstet Gynecol; 2003 May; 101(5 Pt 1):899-904. PubMed ID: 12738147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study.
    McAuliffe FM; Fong KW; Toi A; Chitayat D; Keating S; Johnson JA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1260-5. PubMed ID: 16157148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Birth defects associated with increased nuchal translucency].
    Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
    Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
    Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
    Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
    Atzei A; Gajewska K; Huggon IC; Allan L; Nicolaides KH
    Ultrasound Obstet Gynecol; 2005 Aug; 26(2):154-7. PubMed ID: 15977311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-trimester fetal cardiac examination using spatiotemporal image correlation, tomographic ultrasound and color Doppler imaging for the diagnosis of complex congenital heart disease in high-risk patients.
    Turan S; Turan OM; Desai A; Harman CR; Baschat AA
    Ultrasound Obstet Gynecol; 2014 Nov; 44(5):562-7. PubMed ID: 24585667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal Intracranial Translucency Values During the First Trimester of Gestation in a Latin American Population.
    Molina-Giraldo S; Pérez-Olivo JL; Arias JL; Acuña E; Alfonso D; Arreaza M; Leal MB
    J Ultrasound Med; 2016 Oct; 35(10):2231-6. PubMed ID: 27582529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of the Standardized Early Fetal Heart Assessment in Excluding Major Congenital Heart Defects in High-Risk Population: A Single-Center Experience.
    Turan S; Asoglu MR; Ozdemir H; Seger L; Turan OM
    J Ultrasound Med; 2022 Apr; 41(4):961-969. PubMed ID: 34288033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the nuchal index increased in fetuses with congenital structural heart defects?
    Dahlgren LS; Duncan WJ; Farquarhson DF; Sandor GS; Skoll MA; Tessier F; Lim KI
    Fetal Diagn Ther; 2006; 21(1):96-9. PubMed ID: 16354985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.